Dr. Abraham Sebastian Kanate, MD
- Medicare services, 2024
- 452
- Medicare patients, 2024
- 67
- Part D claims, 2024
- 599
- Publications
- 60
- Clinical trials
- 10
- Practice address
- 9003 East Shea Boulevard, Scottsdale, AZ 85260
- Practice phone
- Call (480) 323-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Kanate's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Abraham Sebastian Kanate is a hematologist and oncologist in Scottsdale, Arizona
Dr. Kanate practices at HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona, part of HonorHealth.
Dr. Kanate's NPI, 1962600965, was assigned on July 11, 2007. Dr. Kanate holds West Virginia license 23230.
- NPI
- 1962600965NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5092969469
- NPI enumeration date
- July 11, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (480) 323-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 49
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Abraham Sebastian Kanate practices at HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona
Dr. Kanate's primary practice is HonorHealth Scottsdale Shea Medical Center, at 9003 East Shea Boulevard, Scottsdale, AZ 85260 in Maricopa County. The practice phone is (480) 323-3000.
- HonorHealth Scottsdale Shea Medical Center9003 East Shea Boulevard, Scottsdale, AZ 85260 · Maricopa CountyPhone(480) 323-3000
Source: Dmand AI Affiliation Data
Dr. Abraham Sebastian Kanate is affiliated with 4 sites of care and 1 medical group
Dr. Kanate's primary practice is HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona, part of HonorHealth. Dr. Kanate is also affiliated with HonorHealth Scottsdale Osborn Medical Center. The medical group on file is HonorHealth Medical Group. Dmand AI also links Dr. Kanate to 1 more hospital and 1 ambulatory surgery center, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Abraham Sebastian Kanate's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanate practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| HonorHealth Scottsdale Shea Medical Center | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across HonorHealth and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Abraham Sebastian Kanate is one of 259 hematologists and oncologists in Arizona
Hematology and oncology is Dr. Kanate's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kanate is licensed in West Virginia.
Specialties and state licenses
- Hematology and oncology, West VirginiaPrimary
Hematologists and oncologists near Dr. Kanate
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Abraham Sebastian Kanate billed Medicare for 452 services in 2024
CMS data shows 452 Medicare services from Dr. Kanate across 5 procedure codes in 2024, for 67 Medicare patients. Medicare paid $25,953 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Kanate's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2902024: 3045%
- Other services
- 2023: 02024: 148
Dr. Kanate compared with the Arizona median for hematologists and oncologists, 2024
- Dr. Kanate
- Arizona median
- Medicare services
- 452vs 2,70583% below
- Medicare patients
- 67vs 37082% below
- Part D claims
- 405vs 404Close to median
Medians across 249 hematologists and oncologists in Arizona with Dmand AI profiles that report each measure.
Dr. Kanate's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kanate?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kanate and other hematologists and oncologists in Arizona.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Abraham Sebastian Kanate treated 67 Medicare patients in 2024, average age 70
CMS counts 67 Medicare patients who saw Dr. Kanate in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 61% have high cholesterol. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kanate's median patient age at 67, with 45% women.
Dr. Kanate's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Kanate's Medicare patients by sex, 2024
- Women2842%
- Men3958%
Chronic conditions among Dr. Kanate's Medicare patients, 2024
- High blood pressure75%
- High cholesterol61%
- Arthritis48%
- Chronic kidney disease37%
- Ischemic heart disease31%
- Anxiety24%
- Atrial fibrillation24%
- Mood disorders24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kanate's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women45%
- Men53%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Abraham Sebastian Kanate wrote 599 Medicare Part D claims in 2024
In 2024, Dr. Kanate wrote 599 Medicare Part D claims for 60 patients. 80% of them were for generic drugs. CMS names the drug for 405 of them, across 17 drugs with 11 or more claims each, at $813,549 in total drug cost. In 2023, CMS named 347 claims across 17 drugs.
Dr. Kanate's Part D claims by kind of drug, 2024
- Generic477 claims80%
- Brand-name and other122 claims20%
Dr. Kanate's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kanate's Part D claims, 2024
- Antibiotics13%78 of 599 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3472024: 40517%
Drugs named by CMS: 17 in 2024, 17 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Abraham Sebastian Kanate scored 82 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Kanate for performance year 2024, reported as part of a group. Dr. Kanate accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Kanate's MIPS scores, performance year 2024
- 82of 100Final score
- 78.7of 100Quality
- 40of 100Improvement Activities
- 78of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Abraham Sebastian Kanate has 60 publications on record
Dmand AI links 60 papers to Dr. Kanate, published from 2012 to 2024. 2017 was the busiest year, with 10. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Antineoplastic Combined Chemotherapy Protocols. Dr. Kanate has published most often in Biol Blood Marrow Transplant. Dr. Kanate's most frequent co-authors are Parameswaran N. Hari, MD, Saurabh Chhabra, MD and Lauren Westfall Veltri, MD.
Dr. Kanate's papers by year, 2015 to 2024
Topics Dr. Kanate writes about most
- Hematopoietic Stem Cell Transplantation
- Transplantation, Homologous
- Antineoplastic Combined Chemotherapy Protocols
- Transplantation, Autologous
- Transplantation Conditioning
- Graft vs Host Disease
- Lymphoma, Non-Hodgkin
- Antigens, CD34
Dr. Kanate's most frequent co-authors
- Parameswaran N. Hari, MD9 shared papers
- Saurabh Chhabra, MD7 shared papers
- Lauren Westfall Veltri, MD7 shared papers
Recent publications by Dr. Kanate
Leuk Lymphoma
Clin Pharmacol Drug Dev
See who Dr. Kanate researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kanate works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Abraham Sebastian Kanate has worked on 10 clinical trials
Dmand AI links Dr. Kanate to 10 clinical trials, 3 of them phase 1/2 studies. 6 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Lymphoma, Non-Hodgkin. ECOG-ACRIN Cancer Research Group sponsors the most, 3.
Clinical trials with Dr. Kanate by phase
- NonePhase 1: no trials
- 3Phase 1/2: 3 trials
- 3Phase 2: 3 trials
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Kanate's trials
- Multiple Myeloma
- Blood Protein Disorders
- Lymphoma, Non-Hodgkin
- Lymphoma, Mantle-Cell
- Anemia, Aplastic
Investigators on the most trials with Dr. Kanate
- Kevin Andrew David, MD3 shared trials
- Vinod Parameswaran, MD3 shared trials
- Victor Chang, MD2 shared trials
Recent clinical trials with Dr. Kanate
A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma (opens in a new tab)
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma (opens in a new tab)
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (opens in a new tab)
Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma (opens in a new tab)
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Abraham Sebastian Kanate received $169,776 in industry payments from 2017 to 2025
CMS Open Payments shows 232 general payments to Dr. Kanate from 25 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Bristol-Myers Squibb Company paid the most, $89,941. It also lists 1 research payment totaling $1,882 in 2020.
General payments to Dr. Kanate by program year, 2017 to 2025
General payments to Dr. Kanate by kind, 2017 to 2025
- Speaker and faculty fees$133,18078%
- Honoraria$12,4007%
- Travel and lodging$10,6346%
- Consulting fees$7,4164%
- Other$6,1464%
Companies that paid Dr. Kanate the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Abraham Sebastian Kanate's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Abraham Sebastian Kanate
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Abraham Sebastian Kanate's NPI number?
Dr. Abraham Sebastian Kanate's NPI number is 1962600965. It was assigned on July 11, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Abraham Sebastian Kanate?
Dr. Abraham Sebastian Kanate is a hematologist and oncologist in Scottsdale, Arizona. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Abraham Sebastian Kanate practice?
Dr. Kanate practices at 9003 East Shea Boulevard, Scottsdale, AZ 85260. Dr. Kanate's primary practice is HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona, part of HonorHealth. Dmand AI also links Dr. Kanate to 1 hospital and 1 ambulatory surgery center.
What is Dr. Abraham Sebastian Kanate's office phone number?
The practice phone on file for Dr. Kanate is (480) 323-3000.
What is Dr. Abraham Sebastian Kanate's medical license number?
Dr. Kanate holds West Virginia license 23230.
Which hospitals is Dr. Abraham Sebastian Kanate affiliated with?
Dr. Kanate practices at HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona. Dr. Kanate is also affiliated with HonorHealth Scottsdale Osborn Medical Center. Dmand AI links Dr. Kanate to 1 more hospital.
What medical group is Dr. Abraham Sebastian Kanate part of?
Dr. Kanate is linked to HonorHealth Medical Group.
Does Dr. Abraham Sebastian Kanate accept Medicare?
Yes. CMS data shows Dr. Kanate billed Medicare for 452 services in 2024, and Dr. Kanate accepts Medicare assignment.
What is Dr. Abraham Sebastian Kanate's MIPS score?
Dr. Kanate's MIPS final score for performance year 2024 is 82 out of 100, reported as part of a group.
How many Medicare patients does Dr. Abraham Sebastian Kanate see?
CMS counts 67 Medicare patients who saw Dr. Kanate in 2024, with an average age of 70.
Show 6 more questionsShow fewer questions
What services does Dr. Abraham Sebastian Kanate bill to Medicare?
In 2024, Dr. Kanate's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and hospital inpatient care (99232).
What drugs does Dr. Abraham Sebastian Kanate prescribe most?
In 2024 Medicare Part D data, Dr. Kanate's most prescribed drugs by claims were Acyclovir, Sulfamethoxazole-Trimethoprim and Prednisone.
Has Dr. Abraham Sebastian Kanate received payments from drug or device companies?
CMS Open Payments shows $169,776 in general payments to Dr. Kanate from 25 companies from 2017 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Abraham Sebastian Kanate been practicing?
Dr. Kanate graduated from medical school in 2003, 23 years ago.
Does Dr. Abraham Sebastian Kanate do research?
Dmand AI links 60 publications to Dr. Kanate, published from 2012 to 2024. Dr. Kanate has worked on 10 clinical trials.
Who does Dr. Abraham Sebastian Kanate publish with?
Dr. Kanate's most frequent co-authors are Parameswaran N. Hari, MD (9 shared papers), Saurabh Chhabra, MD (7 shared papers) and Lauren Westfall Veltri, MD (7 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Arizona by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card